CAMPA, MARIO
 Distribuzione geografica
Continente #
NA - Nord America 11.106
EU - Europa 4.086
AS - Asia 1.640
AF - Africa 89
SA - Sud America 13
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 3
Totale 16.944
Nazione #
US - Stati Uniti d'America 10.811
IT - Italia 999
SE - Svezia 998
CN - Cina 849
DE - Germania 569
BG - Bulgaria 476
CA - Canada 291
TR - Turchia 281
UA - Ucraina 254
GB - Regno Unito 238
FI - Finlandia 210
SG - Singapore 209
VN - Vietnam 179
CH - Svizzera 85
AT - Austria 68
IN - India 61
BE - Belgio 56
RU - Federazione Russa 47
HK - Hong Kong 45
CI - Costa d'Avorio 39
FR - Francia 36
SN - Senegal 30
GR - Grecia 14
NG - Nigeria 14
BR - Brasile 11
IE - Irlanda 5
AL - Albania 4
AU - Australia 4
DK - Danimarca 4
ES - Italia 4
JP - Giappone 4
KR - Corea 4
MX - Messico 4
RO - Romania 4
BJ - Benin 3
CZ - Repubblica Ceca 3
NL - Olanda 3
NZ - Nuova Zelanda 3
PL - Polonia 3
AR - Argentina 2
EU - Europa 2
HU - Ungheria 2
MU - Mauritius 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
EG - Egitto 1
IL - Israele 1
IR - Iran 1
LI - Liechtenstein 1
MD - Moldavia 1
MT - Malta 1
PH - Filippine 1
PK - Pakistan 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
TW - Taiwan 1
Totale 16.944
Città #
Woodbridge 1.754
Ann Arbor 1.627
Houston 1.186
Fairfield 997
Chandler 833
Ashburn 573
Sofia 476
Seattle 372
Wilmington 358
Jacksonville 327
Beijing 323
Cambridge 318
Milan 296
Izmir 277
Ottawa 271
New York 240
Princeton 197
Boardman 193
Lawrence 178
Nanjing 178
Medford 164
Serra 125
Des Moines 112
Dearborn 110
Bremen 90
Singapore 88
Bern 85
San Diego 73
Nanchang 67
Dong Ket 65
Brussels 56
Vienna 56
Jüchen 55
Florence 51
Frankfurt am Main 45
Hong Kong 43
London 43
Chicago 40
Abidjan 39
Boulder 39
Kunming 37
Redwood City 33
Shenyang 32
Falls Church 31
Lancaster 31
Dakar 30
Ogden 27
Tianjin 27
Changsha 26
Norwalk 25
Los Angeles 24
Nürnberg 23
Pisa 23
Pune 23
Rome 23
Hebei 22
Hefei 19
Orange 18
Washington 18
Jiaxing 16
Auburn Hills 15
Guangzhou 14
Lagos 14
Alessandria 13
Changchun 13
Jinan 13
Shanghai 12
Lanzhou 10
Toronto 10
Detroit 9
Marseille 9
Düsseldorf 8
Hangzhou 8
São Paulo 8
Dallas 7
Indiana 7
Phoenix 7
Livorno 6
San Francisco 6
Verona 6
Augusta 5
Edinburgh 5
Lappeenranta 5
Munich 5
Ningbo 5
Dublin 4
Helsinki 4
Redmond 4
San Mateo 4
Tappahannock 4
Walnut 4
Acton 3
Chengdu 3
Copenhagen 3
Cotonou 3
Frosinone 3
Genoa 3
Kent 3
Leawood 3
Lerma 3
Totale 13.199
Nome #
The ESX-5 Associated eccB-eccC Locus Is Essential for Mycobacterium tuberculosis Viability 184
B-CELL-MEDIATED DEPRESSION OF THE GRANULOMATOUS RESPONSE TO BCG IN MICE 167
T and B immunogenicity of SA5K a secretion antigen of Mycobacterium tuberculosis, in healthy subjects and in tuberculosis patients 158
POLYCLONAL B-CELL ACTIVATION IN ANKYLOSING-SPONDYLITIS 156
Human CD56bright and CD56dim Natural Killer Cell Subsets Respond Differentially to Direct Stimulation with Mycobacterium bovis Bacillus Calmette-Guérin 152
FAILURE TO DETECT A LYMPHOCYTE IMBALANCE DURING ACUTE ATTACKS OF PALINDROMIC RHEUMATISM 150
Effect of a novel mucoadhesive polysaccharide obtained from tamarind seeds on the intraocular penetration of gentamicin and ofloxacin in rabbits 149
Genotypic and phenotypic properties of Candida parapsilosis sensu strictu strains isolated from different geographic regions and body sites 148
Involvement of the Mycobacterium tuberculosis secreted antigen SA-5K in intracellular survival of recombinant Mycobacterium smegmatis 147
THE SUPPRESSIVE ACTIVITY OF LYMPHOCYTES-T AND SERUM FACTORS IN BURNED PATIENTS 142
Identification, molecular cloning, and evaluation of potential use of isocitrate dehydrogenase II of Mycobacterium bovis BCG in serodiagnosis of tuberculosis 142
Gastric mucosal distribution and clinical efficacy of azithromycin in patients with Helicobacter pylori related gastritis 141
Influence of culture medium on the resistance and response of Mycobacterium bovis BCG to reactive nitrogen intermediates 140
Effects of Pseudomonas aeruginosa on immune functions. 138
IMMUNE REACTIVITY IN PALINDROMIC RHEUMATISM - RESPONSE TO MITOGENS 137
IMMUNODEPRESSION BY ROWSON-PARR VIRUS IN MICE - EFFECT OF ROWSON-PARR VIRUS AND FRIEND LEUKEMIA COMPLEX INFECTIONS ON CONTACT SENSITIVITY IN SUSCEPTIBLE AND RESISTANT MICE 134
In vitro bactericidal activity of the N-terminal fragment of the frog peptide esculentin-1b (Esc 1-18) in combination with conventional antibiotics against Stenotrophomonas maltophilia 132
Identification of Candida albicans karyotypes characterized by a high proteolytic activity. 131
Mechanisms of NK recognition and activation based on lectin-saccharide interactions 130
A mucoadhesive polymer extracted from tamarind seed improves the intraocular penetration and efficacy of rufloxacin in topical treatment of experimental bacterial keratitis 129
Identification and molecular cloning of a novel secretion antigen from Mycobacterium tuberculosis and Mycobacterium bovis BCG. 127
REVERSAL OF PSEUDOMONAS-AERUGINOSA-INDUCED DISTURBANCE OF LYMPHOCYTE CIRCULATION IN OXAZOLONE-SENSITIZED MICE BY CYCLOPHOSPHAMIDE 127
IMMUNODEPRESSION BY ROWSON-PARR VIRUS IN MICE - EFFECT OF ROWSON-PARR VIRUS AND FRIEND LEUKEMIA COMPLEX INFECTIONS ON BACKGROUND ANTIBODY-FORMING-CELLS TO VARIOUS ERYTHROCYTES 126
An alternative and simple method to consistently prepare viable isolated human islets for clinical transplantation 126
Lung tissue penetration and plasma pharmacokinetics of azithromycin after multiple oral doses of 500 and 1000 mg in adults 125
Purification, biochemical characterization and immunogenicity of SA5K, a secretion antigen of Mycobacterium tuberculosis 125
Periodontal tissue disposition of azithromycin 125
DEPRESSION OF HUMORAL AND CELL-MEDIATED IMMUNE-RESPONSES BY COXSACKIE-VIRUSES IN MICE 123
BACTERIAL-INFECTIONS, IMMUNITY AND REACTIVE ARTHRITIDES 123
Potentiation of the resistance to viral and bacterial infections after pidotimod administration in mice. 123
LPS-INDUCED ENHANCEMENT OF PLAQUE-FORMING CELL RESPONSE TO BROMELAIN-TREATED SYNGENEIC ERYTHROCYTES IN MOUSE PERITONEAL CELL-CULTURES 123
THE PENETRATION OF ROXITHROMYCIN INTO HUMAN SKIN 123
PURINE METABOLISM AND B-LYMPHOCYTE DEVELOPMENT IN THE CHICKEN BURSA OF FABRICIUS 122
Identification of distinct lymphocyte subsets responding to subcellular fractions of Mycobacterium bovis bacille calmette-Guerin (BCG) 122
Enhanced resolution of random amplified polymorphic DNA genotyping of Pseudomonas aeruginosa 121
Internal thiols and reactive oxygen species in candidacidal activity exerted by an N-terminal peptide of human lactoferrin 121
The penetration of roxithromycin into human skin. 121
Molecular basis of resistance to azole antifungals. 119
ENHANCEMENT OF THE SPONTANEOUS DEVELOPMENT OF AUTOREACTIVE-B CELLS BY PPD IN MOUSE PERITONEAL CELL-CULTURES 118
A dynamic analysis of IgM anti-HCV helps to distinguish hepatitis C from acute rejection in liver transplant patients 118
Comparative analysis of subcellular distribution of protein antigens in Mycobacterium bovis Bacillus Calmette-Guerin 118
Disruption of the gene encoding for secretion antigen SA5K affects growth of Mycobacterium bovis bacillus Calmette-Guérin in human macrophages and in mice 118
STAPHYLOCOCCUS-AUREUS INHIBITS CONTACT SENSITIVITY TO OXAZOLONE BY ACTIVATING SUPPRESSOR B-CELLS IN MICE 117
DEPRESSION OF THE ANTIBODY-RESPONSE IN PSEUDOMONAS-AERUGINOSA-INJECTED MICE 117
ROXITHROMYCIN PENETRATION INTO GINGIVA AND ALVEOLAR BONE OF ODONTOIATRIC PATIENTS 117
Analysis of the Mycobacterium bovis hsp60 promoter activity in recombinant Mycobacterium avium 117
ANTI-HAPTEN AND ANTI-IDIOTYPE LYMPHOCYTES-B AND LYMPHOCYTES-T REGULATE CONTACT SENSITIVITY TO OXAZOLONE IN MICE INJECTED WITH PPD 116
Prediction Model on Optionally Substituted 5,6-Membered Fused Ring Systems Containing C and/or N Atoms as Antifungal Agents Against Candida albicans Developed by Data Mining 116
Antimicrobial activity of human hepcidin 20 and 25 against clinically relevant bacterial strains: effect of copper and acidic pH 116
Periodontal tissue disposition of azithromycin in patients affected by chronic inflammatory periodontal diseases 116
Disruption of the ESX-5 system of Mycobacterium tuberculosis causes loss of PPE protein secretion, reduction of cell wall integrity and strong attenuation. 116
Prevalence of Entamoeba histolytica/Entamoeba dispar complex in a group of Saharawi children 115
Comparative distribution of azithromycin in lung tissue of patients given oral daily doses of 500 and 1000 mg 115
Inactivation of polymerase inhibitors for Mycobacterium tuberculosis DNA amplification in sputum by using capture resin 114
BCG-activated NK cells regulate the antibody response to SRBC and restore immune reactivity to PPD in BCG-infected mice 113
Lymphocytic purine metabolic disorders in tubercolin anergic mice 112
Characterization of antigens recognized by new monoclonal antibodies raised against culture filtrate proteins of Mycobacterium bovis bacillus Calmette-Guerin 112
PERIODONTAL TISSUE DISTRIBUTION OF CEFPODOXIME PROXETIL AND EFFICACY IN ACUTE ODONTOGENIC INFECTIONS 111
Evaluation of the inhibitory effects of human serum components on bactericidal activity of human beta defensin 3 111
null 110
POLYCLONAL B-CELL ACTIVATORS INHIBIT CONTACT SENSITIVITY TO OXAZOLONE IN MICE BY POTENTIATING THE PRODUCTION OF ANTI-HAPTEN ANTIBODIES THAT INDUCE T-SUPPRESSOR LYMPHOCYTES ACTING THROUGH THE RELEASE OF SOLUBLE FACTORS 109
DEPRESSION OF CONTACT SENSITIVITY AND ENHANCEMENT OF ANTIBODY-RESPONSE IN PSEUDOMONAS-AERUGINOSA-INFECTED MICE 108
Molecular targeted treatments for fungal infections: the role of drug combinations 108
First characterization in Italy of clinical isolates of mutans streptococci by using specific monoclonal antibodies. 108
STAPHYLOCOCCUS-AUREUS-INDUCED SUPPRESSION OF CONTACT SENSITIVITY IN MICE - SUPPRESSOR CELLS ELICITED BY POLYCLONAL B-CELL ACTIVATION ARE REGULATED BY IDIOTYPE ANTI-IDIOTYPE INTERACTIONS 106
Distribution of azithromycin in plasma and tonsil tissue after repeated oral administration of 10 or 20 milligrams per kilogram in pediatric patients 106
Structure-Activity Relationships on Purine and 2,3-Dihydropurine Derivatives as Antitubercular Agents: a Data Mining Approach 106
Comparative analysis of bactericidal activity of amphibian peptide analogues against multidrug-resistant nosocomial bacterial strains 106
Molecular monitoring of Candida albicans infections in liver transplant recipients 106
Clonaggio molecolare di un nuovo antigene di secrezione di Mycobacterium tuberculosis e Mycobacterium bovis BCG 104
PSEUDOMONAS-AERUGINOSA INFECTION DEPRESSES CONTACT SENSITIVITY TO OXAZOLONE BY ENHANCING SUPPRESSOR CELL-ACTIVITY 104
Effect of removable orthodontic appliances on oral colonisation by mutans streptococci in children 104
Control of Candida albicans murine vaginitis by topical administration of polycarbophil-econazole complex 103
Prediction model on optionalli substituted 5,6-membered fused ring systems containing C and/or N atoms as antifungal agents against Candida albicans developed by data mining 102
PSEUDOMONAS-AERUGINOSA INFECTION - ACTIVATION OF B-SUPPRESSOR CELLS WHICH AFFECT CELL COOPERATION IN THE INDUCTION-PHASE OF CONTACT SENSITIVITY TO OXAZOLONE IN MICE 102
Expression of SA5K, a secretion antigen of Mycobacterium tuberculosis, inside human macrophages and in sputum from tuberculosis patients 101
Increasing serum levels of IgM anti-HCV are diagnostic of recurrent hepatitis C in liver transplant patients with ALT flares 101
EPIDEMIOLOGY AND THERAPY OF CHLAMYDIA-TRACHOMATIS GENITAL-INFECTION IN WOMEN 100
Release of calcium from intracellular stores and subsequent uptake by mitochondria are essential for the candidacidal activity of an N-terminal peptide of human lactoferrin 100
From positive blood culture to microbiological diagnosis in 4 hours by MALDI-TOF mass spectrometry bacterial identification and rapid antibiogram. 98
Human beta-defensin-3: a promising antimicrobial peptide 98
Radiotracers for fungal infection imaging 98
Depression of the immune responsiveness in mice treated with thioacetamide after antigen exposure. 98
Reduced human beta defensin 3 in individuals with periodontal disease 97
Direct binding of human NK cell natural cytotoxicity receptor NKp44 to the surfaces of mycobacteria and other bacteria 97
Suscettibilità di batteri orali alla betadefensina umana 3, 96
QSAR Model on Adenosine Derivatives as Antifungal Agents against Candida albicans: a Data Mining Approach 96
1ST CHARACTERIZATION IN ITALY OF CLINICAL ISOLATES OF MUTANS STREPTOCOCCI BY USING SPECIFIC MONOCLONAL-ANTIBODIES 96
gamma-delta+ and CD4+alpha-beta+ human T cell subset responses upon stimulation with various Mycobacterium tuberculosis soluble extracts 95
DECREASED HUMORAL AND CELL IMMUNITY IN MICE INFECTED WITH COXSACKIE-VIRUS 94
T-SUPPRESSOR CELLS AS WELL AS ANTI-HAPTEN AND ANTI-IDIOTYPE LYMPHOCYTES-B REGULATE CONTACT SENSITIVITY TO OXAZOLONE IN MICE INJECTED WITH PURIFIED PROTEIN DERIVATIVE FROM MYCOBACTERIUM-TUBERCULOSIS 93
TISSUE PENETRATIONS AND EFFICACY OF CEFPODOXIME PROXETIL IN THE TREATMENT OF ODONTOGENIC INFECTIONS 93
Proliferation of distinct human T-cell subsets in response to live, killed or soluble extracts of Mycobacterium tuberculosis and Mycobacterium avium 93
Recurrence of hepatitis B after liver transplantation is associated with intrahepatic HBcAg and serum IgM anti-HBc 93
Identification of a novel Mycobacterium bovis BCG secretion protein 92
DEPRESSION OF CONTACT SENSITIVITY BY PSEUDOMONAS-AERUGINOSA INDUCED SUPPRESSOR CELLS WHICH AFFECT THE INDUCTION-PHASE OF IMMUNE-RESPONSE 92
Functional characterization of human natural killer cells responding to Mycobacterium bovis bacillus Calmette-Guérin 92
CELL-MEDIATED-IMMUNITY AND DELAYED-TYPE HYPERSENSITIVITY IN PSEUDOMONAS AERUGINOSA-INFECTED MICE 91
Activity of human beta-defensin 3 alone or combined with other antimicrobial agents against oral bacteria 91
Incidence of mutans streptococci in insulin-dependent diabetes mellitus patients 90
Totale 11.629
Categoria #
all - tutte 43.700
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.700


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.145 0 0 171 186 254 291 336 196 263 160 234 54
2020/20211.394 108 93 95 72 173 79 77 153 114 111 68 251
2021/20222.094 60 148 33 187 357 265 43 123 69 85 118 606
2022/20232.397 313 320 154 313 240 329 15 191 337 12 148 25
2023/20241.619 227 137 231 83 259 312 31 60 33 29 41 176
2024/2025228 20 197 11 0 0 0 0 0 0 0 0 0
Totale 17.120